Penserra Capital Management LLC Black Diamond Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$5.18 - $8.48 $4,299 - $7,038	-830 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$8.46 - $12.42 $42 - $62	5 Added 0.61%	830 $7,000
Q2 2021 Aug 12, 2021	BUY	$12.19 - $28.17 $60 - $140	5 Added 0.61%	825 $10,000
Q1 2021 May 13, 2021	SELL	$22.23 - $34.75 $111 - $173	-5 Reduced 0.61%	820 $19,000
Q4 2020 Feb 12, 2021	BUY	$29.47 - $35.0 $24,312 - $28,875	825 New	825 $26,000

117

48.8M

1.84M

1.93M

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $91.2M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.